Embryonic stem cells (ESCs) maintain unique epigenetic states to maintain their pluripotency. Differentiation of ESCs into specialized cell types requires changes in these epigenetic states. However, the dynamics of epigenetic marks found in hESCs during differentiation are poorly understood. Here, we report the variation in the dynamics of epigenetic modifications associated with the expression of lineage-specific genes during differentiation of hESCs to hepatocytes in vitro. The promoter regions of pluripotency marker genes characterized by permissive histone marks such as trimethylation of H3 at lysine 4 (H3K4me3) and acetylation of H3 at lysine 9 (H3K9ac) in hESCs were instead enriched with repressive histone marks such as dimethylation of H3 at lysine 9 (H3K9me2), trimethylation of H3 at lysine 9 (H3K9me3) and trimethylation of H3 at lysine 27 (H3K27me3) during differentiation to hepatocytes. Interestingly, expression of definitive endoderm marker genes containing bivalent and non-bivalent domains may be modulated by a marked reduction in H3K27me3 and a significant enhancement of permissive marks such as H3K4me3 and H3K9ac during hESC differentiation. Expression of hepatocyte marker genes regulated by histone modifications was similar to that of pluripotency marker genes. Our findings provide insight into the epigenetic mechanisms regulating expression of developmental genes. Of particular interest, they may be differentially regulated either in a bivalent or non-bivalent domain manner during hESC differentiation.
INTRODUCTION
During development, lineage-determining transcription factors are stochastically regulated by epigenetic alterations that impose a permissive or repressive environment for cell fate (1) . Intracellular networks of these factors are altered to impart a dramatic change in identity upon differentiation (2) . In fact, histone modifications differ between early embryonic lineages such as trophectoderm, primitive endoderm and epiblasts, indicating that epigenetic programs during embryo development are essential for the establishment and maintenance of lineage progenitors in the mouse (3) . Thus, epigenetic modifications of key lineage-specific transcription factor loci lead to the restriction of transcriptional circuits, thereby permitting a specialized lineage or cell fate.
Embryonic stem cells (ESCs) derived from the inner cell mass of an embryo exhibit features both of self-renewal and pluripotency. Pluripotency of ESCs is maintained by unique networks of molecules that are controlled by precise epigenetic cross-talk within higher order chromatin structure, although epigenetic modifications are dynamic and heterogeneous (4 -6) . An underlying interplay between pluripotency factors and epigenetic modifications might be primarily crucial for determining cell fate. The dynamic balance between pluripotency factors and epigenetic modifiers is probably required to form the basis for the pluripotent state (1) . In fact, several epigenetic modifiers that give rise to gene silencing are bound by OCT4, NANOG, SOX2 and SALL4 (Sal-like protein 4) in ESCs (7 -10) .
Gene expression is generally associated with specific posttranslational modifications of histone tails that reside in the promoter regions and transcribed portions of protein-coding genes (11) (12) (13) . Trimethylation of H3 at lysine 4 (H3K4me3) as well as acetylation of H3 at lysine 9 (H3K9ac) are generally * To whom correspondence should be addressed. Tel: +82 423502640; Fax: +82 423508160; Email: ymhan@kaist.ac.kr # The Author 2010. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com found in the promoter regions of actively transcribed genes on nucleosomes (14) (15) (16) (17) , whereas repressive histone marks such as trimethylation of H3 at lysine 27 (H3K27me3) and methylation of H3 at lysine 9 (H3K9me) are responsible for transcriptional repression at promoter regions (7, 18, 19) . In ESCs, both H3K4me3 and H3K27me3, named bivalent domains, are found to coexist in promoter regions of lineage-specific genes such as developmental genes. These bivalent domains play an important role in the maintenance of pluripotency in both mouse and human ESCs (20, 21) , and shift to only one type of modification during the differentiation of ESCs, depending on the commitment to lineage-specific cells (22) . Recently, large-scale analyses of histone modifications revealed the expansion of H3K27me3 and H3K9me3 domains in differentiated cells relative to hESCs, which selectively affects genes related to pluripotency, development and lineage-specific functions (23) . These bivalent domains are essential for differentiation of hESCs to neural stem cells as well as b-III tubulin-positive neurons (24) . During differentiation of hESCs to a definitive endoderm (DE) lineage, however, epigenetic behaviors of lineage-specific genes in terms of permissive and repressive histone marks are poorly understood.
Here, we investigated epigenetic behaviors of lineagespecific genes in terms of the histone modification and DNA methylation in hESCs during differentiation to hepatocytes. As a result, we found that the expression of pluripotency marker genes such as OCT4, SOX2 and NANOG was modulated by typical epigenetic modification modes during hESC differentiation to hepatocytes. Out of DE marker genes examined in this study, promoter regions of SOX17 (SRY-box 17), GATA4 (GATA binding protein 4) and FOXA2 (forkhead box A2) genes retained bivalent domains, whereas CXCR4 (CXC motif receptor 4) did not have bivalent domains in hESCs. After induction of hESCs to the DE lineage, only the repressive mark H3K27me3 of the bivalent domains in SOX17, GATA4 and FOXA2 genes was significantly reduced along with a decrease in permissive histone marks. On the other hand, promoter regions of DE marker genes containing nonbivalent domains were switched to the transcriptional mode characterized by H3K4me3 during transition of hESCs to DE cells. In addition, temporal expression of DE marker genes might not be associated with DNA methylation because under-methylation of the promoter regions is maintained throughout hESC differentiation. Unlike early developmental genes, terminally differentiated marker genes such as hepatocyte marker genes did not have bivalent domains in hESCs. These results demonstrate that epigenetic regulation for temporal expression of lineage-specific genes is slightly different from one gene to another during hESC differentiation.
RESULTS

Differentiation of hESCs to hepatocytes in vitro
This study was carried out to understand epigenetic behaviors such as histone modifications and DNA methylation during differentiation of hESCs to hepatocytes. hESCs were induced into DE cells by treatment with Activin A for 5 days under serum-free conditions. Approximately 90% of Activin A-treated cells were stained positive for CXCR4 antibody (Fig. 1A) and expressed DE marker SOX17 (Fig. 1B) . hESC-derived DE cells were further differentiated to hepatocytes as described in the Materials and Methods. Most of the resultant hepatocytes expressed AAT and AFP in the cytoplasm (Fig. 1B) and secreted albumin into the culture medium at the concentration of about 40 ng/ml (Fig. 1C) . They were also able to store glycogen in the cytoplasm and take up acetylated low-density lipoprotein (LDL) (Fig. 1D ). These results demonstrate that hESC-derived hepatocytes possess at least a subset of the cellular and molecular characteristics of adult liver cells.
Epigenetic modifications of pluripotency marker genes in hESCs during differentiation to hepatocytes
Core pluripotency factors such as OCT4, SOX2 and NANOG collaborate to form a regulatory circuitry consisting of feedforward and autoregulatory loops to maintain the unique features of hESCs (25) . Transcription of pluripotency marker genes was enhanced in hESCs and significantly decreased during differentiation into hepatocytes ( Fig. 2A) Figure 2B (right panel), permissive histone marks such as H3K4me3 and H3K9ac were enriched within the promoter of OCT4 in hESCs but abruptly decreased in DE cells and hepatocytes. Repressive histone marks H3K27me3 and H3K9me2 represented a gradual increment during differentiation of hESCs to hepatocytes, thereby leading to complete silencing of this gene. Modification of H3K9me3 at the OCT4 promoter was maintained throughout hESC differentiation (Fig. 2B, right panel) . This study indicates that slight expression of OCT4 in DE cells may be regulated by the activity of H3K9ac. Silencing of the OCT4 gene in CRL fibroblasts was likely governed by all three repressive histone modifications (Fig. 2B, right panel) . These findings demonstrate that the transcription of OCT4 is activated in hESCs by the permissive marks H3K4me3 and H3K9ac, and is suppressed in DE cells and hepatocytes by the repressive marks H3K27me3 and H3K9me2, as well as DNA methylation at the promoter region.
The SOX2 promoter region, containing 19 CpG dinucleotides, was completely unmethylated in all lineage cells (Fig. 2C, left panel) . According to quantitative ChIP-PCR, both permissive marks H3K4me3 and H3K9ac were predominant in hESCs, but not detected in DE cells, hepatocytes and CRL fibroblasts (Fig. 2C, right (Fig. 2D, left panel) . Permissive histone marks in the promoter region of NANOG abruptly decreased during differentiation of hESCs to hepatocytes. Repression of the NANOG gene seemed to be governed in DE cells by H3K27me3 and H3K9me2, and in hepatocytes by a paucity of H3K4me3 and H3K27me3 (Fig. 2D, right panel) . Silencing of this gene in CRL fibroblasts was likely regulated by all three repressive histone modifications. These results demonstrate that repressive histone modifications and DNA methylation suppress the expression of the NANOG gene in hESCs during differentiation to hepatocytes.
Epigenetic modifications of DE marker genes in hESCs during differentiation to hepatocytes
DE marker genes such as SOX17, GATA4, FOXA2 and CXCR4 were highly expressed in DE cells but only weakly transcribed in hepatocytes ( (Fig. 3A) , histone modifications of the promoter region were bivalent in that both permissive and repressive histone marks were enriched (Fig. 3B , right panel). Extreme enrichment of H3K27me3 in hESCs seems to suppress activation of the SOX17 gene. Furthermore, modifications of both permissive and all repressive histone marks were reduced during differentiation of hESCs into hepatocytes. Therefore, the SOX17 gene in DE cells is likely activated by demethylation of H3K27 rather than trimethylation of H3K4. Silencing of the SOX17 gene in hESC-derived hepatocytes is likely completed by dominant occupancy of H3K27me3 on its promoter. However, H3K9me2 and H3K9me3 did not appear to play an important role in the regulation of the SOX17 expression in both DE cells and hepatocytes. Expression of the SOX17 gene in CRL fibroblasts was suppressed by all repressive histone marks. Therefore, we suggest that H3K27me3 may function as a key regulator for the expression of SOX17 during differentiation of hESCs to hepatocytes.
The GATA4 promoter region, containing 40 CpG dinucleotides, was completely unmethylated throughout the differentiation of hESCs to hepatocytes (Fig. 3C, left panel) . The GATA4 promoter region was modified by H3K4me3, H3K9ac and H3K27me3 in hESCs (Fig. 3C , right panel). H3K27me3 largely disappeared, whereas H3K4me3 was highly enhanced during the differentiation of hESCs to DE cells. Although H3K9me2 and H3K9me3 were present at basal levels when compared with the IgG control in hESCs, modifications of H3K9 were dynamic. The abundant acetylation of H3K9 in hESCs remarkably decreased, whereas diand trimethylation of H3K9 increased in DE cells (Fig. 3C , right panel). From these results, we conclude that specific expression of GATA4 in DE cells is modulated by trimethylation of H3K4 and demethylation of H3K27. The GATA4 gene was also weakly transcribed in hepatocytes (Fig. 3A) . It is conceivable that this gene expression in hepatocytes may be mainly activated by acetylation of H3K9. Interestingly, silencing of the GATA4 gene in CRL fibroblasts was mainly modulated by prevalence of H3K27me3 and a paucity of permissive marks.
The FOXA2 promoter region, including 26 CpG dinucleotides, presented a hypomethylated status in all cell types (Fig. 3D , left panel). Co-occupancy of permissive marks (H3K4me3 and H3K9ac) and repressive marks (H3K27me3 and H3K9me3) was detected at the promoter region of the FOXA2 gene in hESCs (Fig. 3D , right panel). This gene is likely to be suppressed in hESCs by H3K27me3 and H3K9me3, despite the presence of permissive marks. Levels of H3K4me3 and H3K9ac in DE cells were decreased compared with hESCs, and H3K27me3 completely disappeared during differentiation of hESCs to DE cells (Fig. 3D, right  panel) . Thus, expression of the FOXA2 gene in DE cells appears to be modulated by demethylation of H3K27. Our findings indicate that the expression of SOX17, GATA4 and FOXA2 genes may be regulated by the trimethylation state of histone H3K27 during differentiation of hESCs to DE cells.
An unmethylated state of the CXCR4 promoter region, containing 43 CpG dinucleotides, was maintained throughout the differentiation of hESCs to hepatocytes (Fig. 3E, left panel) . Frequencies of H3K4me3 and H3K9ac were enhanced, while those of H3K27me3, H3K9me2 and H3K9me3 were not 
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Human Molecular Genetics, 2011, Vol. 20, No. 3 Epigenetic modifications of hepatocyte marker genes in hESCs during differentiation to hepatocytes Figure 4A illustrates the transcription of hepatocyte marker genes. Interestingly, expression of HNF4A (hepatocyte nuclear factor 4-a) was not detected in hESCs, but was activated in DE cells. Given that HNF4A is also a DE marker (26, 27) , this result implies that hESC-derived DE cells may have a predisposition to develop into hepatocytes. Also, like HepG2 cancer cells, other hepatocyte marker genes such as a-1-antitrysin (AAT), glucose-6-phosphatase (G6P) and cytochrome enzymes (CYP2B6 and CYP3A4) were transcriptionally expressed in hESC-derived hepatocytes (Supplementary Material, Fig. S2B ).
The ALB (albumin) promoter region, encompassing seven CpG dinucleotides, was highly methylated in hESCs, DE cells and hepatocytes (Fig. 4B, left panel) . During hESC differentiation, H3K4me3 in the ALB promoter region was increased only in hepatocytes, while levels of H3K4me3 and H3K9ac were similar to those of IgG controls in hESCs and DE cells (Fig. 4B, right panel) , indicating that H3K4me3 is a key modulator in the expression of the ALB gene. Repression of ALB in hESCs correlated with the existence of H3K27me3. Three repressive histone marks were enriched in the ALB promoter region in DE cells, coinciding with suppression of the gene. Repression of the ALB gene in CRL fibroblasts did not seem to be influenced by histone modifications because of low frequencies of both permissive and repressive histone marks.
Bisulfite sequencing of the HNF4A promoter region, containing 19 CpG dinucleotides, detected methylation levels of 98.9% (94/95), 84.2% (80/95) and 51.6% (49/95) in hESCs, DE cells and hepatocytes, respectively (Fig. 4C, left panel) . This gradual decrease in the methylation level was inversely associated with the gradual increase in the HNF4A gene expression during hESC differentiation. Also, a gradual increment of gene expression was consistent with competitive behaviors between permissive and repressive histone marks (Fig. 4C, right panel) . Like in the ALB gene, histone modifications in CRL fibroblasts were unlikely to be significant for regulation of the HNF4A gene. These findings indicate that expression of the HNF4A gene is modulated by both DNA methylation and histone modifications during differentiation of hESCs into hepatocytes. In hESC-derived hepatocytes, the AFP promoter region was mainly occupied with permissive marks H3K4me3 and H3K9ac (Fig. 4D) . Interestingly, a paucity of H3K27me3 was observed in the promoter region of this gene in hESCs. Instead, di-and trimethylation of H3K9 were responsible for the suppression of this gene in hESCs. H3K27me3 and H3K9me2 probably act to repress expression of this gene in DE cells. Also, expression of the TDO2 (tryptophan 2,3-dioxygenase) gene in hepatocytes seemed to be regulated only by permissive marks H3K4me3 and H3K9ac (Fig. 4E) . Suppression of TDO2 in DE cells is likely governed by an enrichment of repressive histone marks H3k27me3 and H3K9me2. Unlike the AFP gene, intriguingly, the silenced TDO2 gene showed bivalent histone modifications in CRL fibroblasts. The methylation states of these genes could not be investigated due to the absence of CpG dinucleotides in their promoter regions.
DISCUSSION
Differentiation of hESCs is an excellent model for understanding molecular mechanisms of human developmental processes because hESCs can differentiate into all cell types. Unique epigenetic states present in ESCs are responsible for positively or negatively modulating expression of lineage-specific genes, which is required for the maintenance of pluripotency. Differentiation of ESCs into a specialized cell type should require dramatic changes of epigenetic states for expression of lineage-determining genes. Here, we investigated epigenetic marks such as histone modifications and DNA methylation at the promoters of lineage-specific genes in hESCs during differentiation into hepatocytes in vitro. This study indicates that temporal expression of lineage-specific genes is regulated by unique epigenetic modifications during hESC differentiation. In addition, profiling of histone modifications in hESCderived hepatocytes was remarkably distinct from that of CRL fibroblasts as a differentiated cell control. Thus, it is concluded that most of lineage-specific genes have unique epigenetic signatures during hESC differentiation.
A canonical epigenetic regulation is represented by the expression of pluripotency marker genes in hESCs during differentiation to hepatocytes. In hESCs, core transcriptional factors such as OCT4, SOX2 and NANOG are essential for maintaining pluripotency and self-renewal by forming a regulatory circuitry that is composed of autoregulatory and feedforward loops (25) . Expression of pluripotency marker genes such as OCT4 and NANOG is consistent with the epigenetic states of permissive histone marks and DNA hypomethylation in the promoters of these genes in hESCs (Fig. 2) . These results are consistent with previous reports indicating that H3K4me3 and H3K9ac are present at actively transcribed gene promoters in hESCs (28, 29) . Whole-genome mapping for H3K4me3 and H3K27me3 shows that pluripotency marker genes are changed from a chromatin state modified by H3K4me3 alone to the presence of both modifications during hESC differentiation after treatment with retinoic acid (RA) (21) . However, this study presents data suggesting that silencing of pluripotency marker genes in hESC derivatives is predominantly governed by repressive histone marks. Nonetheless, we demonstrate that suppression mechanisms governed by repressive histone marks are slightly different from one gene to another during hESC differentiation to hepatocytes (Fig. 2) . Repression of OCT4 may be predominantly regulated in DE cells by H3K27me3 and H3K9me3 and in hepatocytes by H3K27me3 and H3K9me2, along with a gradual increase in DNA methylation (Fig. 2B) . Three repressive histone marks may be involved in the repression of the SOX2 gene (Fig. 2C) . Transcription of NANOG appears to be suppressed in DE cells by H3K27me3 and H3K9me2 and in hepatocytes by a paucity of H3K4me3 and H3K27me3 (Fig. 2D) . Moreover, methylation of CpG dinucleotides gradually increased in the promoter region of NANOG during differentiation of hESCs to hepatocytes. The incremental increase in DNA methylation was inversely correlated with the gradual decrease in OCT4 and NANOG expression upon differentiation of hESCs (Fig. 2) . Our data are consistent with the previous reports that the OCT4 and NANOG promoters are methylated at CpG sites in RA-treated ESCs to maintain silencing of these genes (30, 31) .
A number of developmental genes maintain a bivalent chromatin structure in which H3K4me3 is colocalized with H3K27me3 in mouse ESCs and hESCs (20) (21) (22) 32) . Here, we also observed bivalent histone modifications in the promoters of some DE marker genes (SOX17, GATA4 and FOXA2) in hESCs (Fig. 3) . In contrast, histone modifications of most pluripotency and hepatocyte marker genes are not bivalent in promoter regions in hESCs (Figs 2 and 4) . During hESC differentiation, bivalent histone modifications of DE marker genes are shifted to the transcriptional mode in a gene-specific manner. As shown in Figure 3B , expression of the SOX17 gene in DE cells appears to be activated by demethylation of histone H3 at lysine 27, whereas suppression of this gene in hepatocytes seems to be modulated by the methylation of H3K27. Similarly, cooperative interactions of permissive and repressive marks support higher expression of the GATA4 gene in DE cells (Fig. 3C) . Weak expression of GATA4 in hepatocytes may arise from the acetylation of histone H3 at lysine 9. Figure 3D demonstrates that complete demethylation of histone H3 at lysine 27 may result in high expression of the FOXA2 gene in DE cells because the occupancy of permissive histone marks are also reduced on the promoter. Therefore, the low expression level of FOXA2 may be due to the slight increase in H3K27me3 observed during differentiation of DE cells to hepatocytes. Among the DE marker genes examined, CXCR4 presented the most typical regulation of expression by histone modification during hESC differentiation (Fig. 3E) . As shown in Figure 3 , lack of DNA methylation in the promoter regions of DE marker genes is maintained throughout the hESC differentiation. This result
implies that the expression of DE marker genes does not seem to be affected by DNA methylation of the promoter regions. Repression of lineage-specific genes occupied by bivalent domains in hESCs might be responsible for a more dominant role for H3K27me3 compared with H3K4me3. During differentiation into a specialized lineage, the bivalent domains in genes required to maintain identity of a specific cell type might be switched to a more permissive transcriptional mode. However, all promoter loci of lineage-specific genes do not contain bivalent domains in hESCs. In fact, some developmental genes are marked only by the permissive H3K4me3 and H3 acetylation marks in mouse ESCs (33) , and H3K27me3 is associated with widespread repression of developmental genes in hESCs (21) . Mechanisms explaining how developmental genes are kept silent in ESCs remain elusive. It is likely that these genes become permissive for activation at a particular developmental stage of differentiation via unknown epigenetic mechanisms. Expression of hepatocyte marker genes is closely correlated with histone modifications in their promoter regions during differentiation of hESCs to hepatocytes (Fig. 4) . Repressive histone marks enriched in the promoters of hepatocyte marker genes in hESCs and DE cells are replaced with permissive histone marks in hepatocytes, thereby resulting in the activation of hepatocyte marker genes. In particular, H3K4me3 appears to be a key regulator in the expression of hepatocyte marker genes such as ALB, HNF4A and AFP, and TDO2 genes in hESCderived hepatocytes. Unlike other hepatocyte marker genes, abundant expression of the HNF4A gene in hepatocytes seems to arise from the synergistic effect of permissive histone modifications along with partial DNA demethylation. With the exception of AFP, repression of hepatocyte marker genes in other cells of this lineage may be governed by H3K27me3. Similarly, gene repression of many neuron-specific genes by H3K27me3 is observed at the progenitor stage during the differentiation of mouse ESCs into neurons (34) . H3K27 methylation is critical for repressing expression of lineage-specific genes in ESCs (20, 35) .
In summary, this study presents a more complete picture of the dynamics in histone modifications in the promoters of lineage-specific genes in hESCs during differentiation into hepatocytes in vitro. We observed that expression of pluripotency marker genes is regulated by a typical epigenetic regulation mode that is activated by permissive histone marks and suppressed by repressive histone marks. We also observed bivalent histone modifications in the promoters of some DE marker genes (SOX17, GATA4 and FOXA2) in hESCs. During hESC differentiation, expression of DE marker genes containing bivalent domains was modulated by a remarkable reduction of H3K27me3, whereas DE marker genes containing non-bivalent domains were transcriptionally activated by the enrichment of permissive marks such as H3K4me3 and H3K9ac. This result suggests that expression of developmental genes containing bivalent domains might be controlled by the relaxation of repressive histone markers or by unknown epigenetic mechanisms during development. Transcriptional expression of hepatocyte marker genes by histone modifications was similar to that of pluripotency marker genes. Our findings provide an in vitro model of epigenetic mechanisms involved in human hepatocyte development.
MATERIALS AND METHODS
Differentiation of hESCs to hepatocytes
Human ESCs (CHA-hES4 cell line) were maintained as previously described (36) . Differentiation of hESCs into hepatocytes was carried out as previously described (37) and the procedures are detailed in Supplementary Material, Fig. S1 . Briefly, hESCs were cultured to confluency in CM using a feeder-free system for 3 days. Then, hESCs were incubated in RPMI-1640 (Hyclone, Logan, UT, USA) containing 0.5 mg/ml albumin fraction V (Sigma-Aldrich, St Louis, MO, USA) and 50 ng/ml Activin A (Peprotech, Rocky Hill, NJ, USA) for 1 day, and further cultured in the same RPMI medium supplemented with 1% insulin -transferrin -selenium (Sigma-Aldrich) for 4 days. After treatment with Activin A, the differentiated cells were cultured in hepatocyte culture medium (HCM, Lonza, Baltimore, MD, USA) containing 30 ng/ml fibroblast growth factor 4 (Peprotech) and 20 ng/ml bone morphogenetic protein 2 (Peprotech) for 5 days, and further cultured in HCM supplemented 20 ng/ml hepatocyte growth factor (Peprotech) for 5 days. Maturation of hESCderived hepatocytes was induced by culturing in HCM supplemented with 10 ng/ml oncostatin M (R&D Systems, Minneapolis, MN, USA) and 0.1 mM dexamethasone (Sigma-Aldrich) for 5 days. The culture media were changed daily. As a control, human foreskin fibroblasts were used in this study. Human foreskin fibroblast cell line (CRL-2097 TM ) was purchased from American Type Culture Collection (ATCC, Manassas, VA, USA) and cultured in DMEM (WelGENE Inc., Daegu, Korea) containing 10% FBS (Invitrogen, Carlsbad, CA, USA), 1% NEAA (Invitrogen) and 1% penicillin -streptomycin (Invitrogen).
Real-time reverse transcription -PCR (RT -PCR)
Total RNA was isolated from cells using TRIzol Reagent (Invitrogen) and reverse-transcribed using M-MLV Reverse Transcriptase (Enzynomics, Seoul, Korea) according to the manufacturer's protocol. The primers used in this study are listed in Supplementary Material, Table S1 . The expression level of respective genes was measured by real-time RT -PCR using 2 × Prime Q-Master Mix (GENET BIO, Seoul, Korea). Relative expression level was analyzed by using an iCycler iQ5 Real-Time detection system (Bio-Rad Laboratories, Hercules, CA, USA). The reaction parameters for real-time RT -PCR analysis were 958C for 10 min followed by 40 cycles of 958C for 30 s, 608C for 30 s and 728C for 30 s, and a final elongation step at 728C for 5 min. All reactions were repeated more than two times. For comparative quantification, the expression levels of genes of interest were normalized to that of GAPDH (glyceraldehyde-3-phosphate dehydrogenase) and expressed as fold-change relative to the expression level of undifferentiated hESCs. The sample DCt (SDCt) value was calculated as the difference between the Ct values of GAPDH and the target. The DCt value of undifferentiated hESCs was used as a control DCt (CDCt) value. The relative gene expression levels between the sample and the control were determined using the formula 2 2(SDCt2CDCt) . 
Analyses for functionality of hESC-derived hepatocytes
The functionality of hESC-derived hepatocytes was analyzed in terms of albumin secretion, glycogen storage and acetylated LDL (Ac-LDL) uptake. The amount of albumin secreted into the medium in hESC-derived hepatocytes was measured using a human albumin ELISA Quantitation kit (Bethyl Laboratory, Montgomery, TX, USA) on a Bio Rad Model 680 microplate reader. One hundred microliter of supernatant sampled from two culture dishes was used to measure the average amount of secreted albumin.
The glycogen storage assay was conducted using the PAS (Periodic acid-Schiff) staining system (Sigma-Aldrich). hESCderived hepatocytes were fixed in 4% formaldehyde for 30 min, rinsed three times in PBST for 10 min, permeabilized with PBS containing 0.1% Triton X-100 for 15 min and rinsed three times in PBST. Samples were then oxidized in 1% periodic acid for 5 min, rinsed three times in distilled water, treated with Schiff's reagent for 15 min and rinsed in distilled water for 10 min. Samples were counterstained with hematoxylin for 1 min, rinsed in distilled water and observed under white light on an inverted microscope (Olympus, Tokyo, Japan).
For the Ac-LDL uptake assay, hESC-derived hepatocytes were incubated with 10 mg/ml of 1,1 ′ -dioctadecyl-3,3,3 ′ ,3 ′ -tetramethylindocarbocyanine (Dil)-labeled Ac-LDL (Invitrogen) for 5 h. Red fluorescent signals were visualized via fluorescence microscopy.
Chromatin immunoprecipitation (ChIP) analysis
The chromatin immunoprecipitation (ChIP) assay was performed as previously described (38) . Briefly, approximately 1 × 10 6 cells were incubated in cell culture medium containing 1.2% formaldehyde at 258C for 10 min and quenched by the addition of 0.123 M glycine for 5 min at 258C. Cells were harvested by scraping, washed twice in phosphate-buffered saline and three times in ChIP lysis buffer, and resuspended in 200 ml of the ChIP lysis buffer containing high salt. Crosslinked chromatin was fragmented by sonication and pre-cleared with protein A/G PLUS agarose (Santa Cruz Biotechnology) at 48C for 30 min. Each primary antibody was incubated overnight with chromatin at 48C. Antibodies (Millipore-Upstate, Temecula, CA, USA) used for the ChIP assay were as follows: normal rabbit IgG (#12-370), anti-trimethyl-H3K4 (#04-745), anti-trimethyl-H3K27 (#07-449), anti-dimethyl-H3K9 (#07-441), anti-trimethyl-H3K9 (#07-442) and anti-acetyl-H3K9 (#06-942). Immunocomplexes were harvested by incubation with protein A/G PLUS agarose for 2 h at 48C. Immunoprecipitates were washed twice with lysis buffer containing high salt and rinsed four times with wash buffer. Samples were resuspended in elution buffer and incubated at 678C overnight. DNA samples were isolated using phenol/ chloroform extraction, precipitated with ethanol and resuspended in 50 ml of TE buffer. Quantitative PCR was carried out on an iQ5 Real-Time PCR Detection System (Bio-Rad Laboratories). The primer sequences and annealing temperatures used for PCR are shown in Supplementary Material, Table S2 . ChIP-qPCR results were calculated using the DDCt method. The Ct value of the respective ChIP fraction was normalized against the Ct value of the input DNA fraction (DCt). Then, the Ct value of the ChIP fraction was again normalized to the Ct value of the IgG control (DDCt). Fold enrichment of immunoprecipitation was calculated by 2
2△△Ct
. The GAPDH gene was used as a loading control (Supplementary Material, Fig. S3 ).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
Conflict of Interest statement. None declared.
FUNDING
